Abstract
The effect of systemic 8-methoxypsoralen (8-MOP; 100 mg/kg daily) and subsequent long ultraviolet irradiation (UVA; 300 mJ/cm2; peak: 365 nm) on albino and pigmented rat eyes was studied in a 3-dimensional experimental set-up. While 8-MOP and UVA did not cause any ocular pathology when administered alone, a combined application of the two factors caused reversible corneal opacities, and irreversible iris devascularisation and cataracts. The irreversible changes were seen only in the albinos and accompanied by a significant decrease in lens wet weight. Phosphorescence and EPR spectroscopy demonstrated the formation of an 8-MOP-protein photoadduct in the animals treated with both 8-MOP and UVA. The results of this study emphasize the necessity of shielding the eyes of patients on photochemotherapy with protective spectacles.
Similar content being viewed by others
References
Bäck O, Hollström E, Lidén S, Thorburn W (1979) Absence of cataract ten years after treatment with 8-methoxypsoralen. Acta Dermatovener 60: 79–80
Carlo E (1914) Le cristallin est-il susceptible d'être lésé par les radiations violettes et ultraviolettes? Ann Oculist (Paris) 152: 41–44
Cloud TM, Hakim R, Griffin AC (1960) Photosensitization of the eye with methoxsalen. I: Acute effects. Arch Ophthal (Chicago) 64: 346–351
Cloud TM, Hakim R, Griffin AC (1961) Photosensitization of the eye with methoxsalen. II: Chronic effects. Arch Ophthal (Chicago) 66: 689–693 (1961)
Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Amer Statist Ass 50: 1096–1121
El Mofty AM (1948) A preliminary clinical report on the treatment of leukoderma with Ammi majus Linn. J Roy Egypt MA 31: 651–665
Fitzpatrick TB, Pathak MA (1959) Historical aspects of methoxypsoralen and furocoumarin. J invest Dermatol 32: 229–231
Freeman RG (1966) Morphologic changes resulting from photosensitization of the eye with 8-methoxypsoralen — A comparison with conventional ultraviolet injury. Texas Rep Biol Med 24: 588–596
Freeman RG, Troll D (1969) Photosensitization of the eye by 8-methoxypsoralen. J invest Dermatol 53: 449–453
Gschnait F (1977) Orale Photochemotherapie. Wien klin Wschr 89: (Suppl. 75), 1–30
Jose JG (1978) The role of DNA damage, its repair and misrepair in the etiology of cataract: a review. Ophthal Res 10: 52–62
Jose JG, Yielding KL (1978) Photosensitive cataractogens, chlorpromazine and methoxypsoralen, cause DNA repair synthesis in lens epithelial cells. Invest Ophthal 17: 687–691
Koch H-R, Beitzen R, Kremer F, Lerman S (1979) Effect of 8-methoxypsoralen and long UV on the rat lens. Invest Ophthal 18(Suppl): 218
Koch H-R, Kremer F, Stein G (1981) Schutzbrillen für die Photochemotherapie. Augenarzt 15: 10–13
Lerman S (1980) Biological and chemical effects of ultraviolet radiation. In: Radiant Energy and the Eye. p. 115–186. Macmillan: New York
Lerman S (1981) Ocular phototoxicity and PUVA therapy: An experimental and clinical examination. FDA Symposium, Bethesda, Maryland
Lerman S, Borkman RF (1977) A method for detecting 8-methoxypsoralen in the ocular lens. Science 197: 1287–1288
Lerman S, Hockwin O (1981) UV-visible slit lamp densitography of the human eye. Exp Eye Res 33: 587–596
Lerman S, Koch H-R (1981) Die Photochemotherapie: Zur Frage ihrer Nebenwirkungen am Auge. Klin Mbl Augenheilk 178: 347–349
Lerman S, Jocoy M, Borkman RF (1977) Photosensitization of the lens by 8-methoxypsoralen. Invest ophthal 16: 1065–1068
Lerman S, Megaw J, Willis I (1980a) The photoreaction of 8-MOP with tryptophan and lens proteins. Photochem Photobiol 31: 235–243
Lerman S, Megaw J, Willis I (1980b) Potential ocular complications of PUVA therapy and their prevention. J invest Dermatol 74: 197–199
Lerman S, Hockwin O, Dragomirescu V (1981a) In vivo lens fluorescence photography. Ophthal Res 13: 224–228
Lerman S, Megaw J, Gardner K, Takei Y, Willis I (1981b) Localisation of 8-methoxypsoralen in ocular tissues. Ophthal Res 13: 106–116
Lerman S, Gardner K, Megaw J, Borkman R (1981c) Prevention of direct and photosensitized ultraviolet radiation damage to the ocular lens. Ophthal Res 13: 284–292
Megaw J, Lee J, Lerman S (1980) NMR analyses of tryptophan-8-methoxypsoralen photoreaction products. Photochem Photobiol 32: 265–270
Mortazawi SAM, Oberste-Lehn H (1973) Lichtsensibilisatoren und ihre therapeutischen Fähigkeiten. Erste vorläufige Mitteilung. Z Haut-Geschlkr 48: 1–9
Parrish JA, Chylack LT, Woehler ME, Cheng H-M, Pathak MA, Morison WL, Krugler J, Nelson WF (1979) Dermatological and ocular examinations in rabbits chronically photosensitized with methoxsalen. J invest Dermatol 73: 250–255
Scott BR, Pathak MA, Mohn GR (1976) Molecular and genetic basis of furocoumarin reactions. Mutation Res 39: 29–74
Tronnier H, Schüle D (1973) Zur dermatologischen Therapie von Dermatosen mit langwelligem UV nach Photosensibilisierung der Haut mit Methoxsalen. Erste Ergebnisse bei der Psoriasis vulgaris. Z Haut-Geschlkr 48: 385–393
Weber G (1974) Combined 8-methoxypsoralen and black light therapy of psoriasis: Technique and results. Brit J Dermatol 90: 317–323
Zigman S, Vaughan T (1974) Near ultraviolet light effects on the lenses and retinas of mice. Invest Ophthal 13: 462–465
Zigman S, Yulo T, Schultz J (1974) Cataract induction in mice exposed to near UV light. Ophthal Res 6: 259–270
Zigman S, Datiles M, Torcyznski E (1979) Sunlight and human cataracts. Invest Ophthal 18: 462–467
Author information
Authors and Affiliations
Additional information
A preliminary report of these results was presented as a poster at the 1979 ARVO meeting (cf. Koch et al. 1979)
Rights and permissions
About this article
Cite this article
Koch, H.R., Beitzen, R., Kremer, F. et al. 8-methoxypsoralen and long ultraviolet effects on the rat lens: Experiments with high dosage. Graefe's Arch Clin Exp Ophthalmol 218, 193–199 (1982). https://doi.org/10.1007/BF02150094
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02150094